Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 24, Issue 5, Pages 479-488
Publisher
Mary Ann Liebert Inc
Online
2013-03-23
DOI
10.1089/hum.2012.234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Rescue of Dystrophin Expression and Improvement in Muscle Pathology and Function in Dystrophic mdx Mice by Peptide-Conjugated Morpholino
- (2012) Bo Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Engineering Multiple U7snRNA Constructs to Induce Single and Multiexon-skipping for Duchenne Muscular Dystrophy
- (2012) Aurélie Goyenvalle et al. MOLECULAR THERAPY
- Test–retest reliability and developmental evolution of the 6-min walk test in Caucasian boys aged 5–12years
- (2012) Nathalie Goemans et al. NEUROMUSCULAR DISORDERS
- Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery
- (2012) Y. Aoki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
- (2012) Corinne Betts et al. Molecular Therapy-Nucleic Acids
- Delivery of AAV2/9-Microdystrophin Genes Incorporating Helix 1 of the Coiled-Coil Motif in the C-Terminal Domain of Dystrophin Improves Muscle Pathology and Restores the Level of α1-Syntrophin and α-Dystrobrevin in Skeletal Muscles of mdx Mice
- (2011) Taeyoung Koo et al. HUMAN GENE THERAPY
- Repeat-Dose Toxicology Evaluation in Cynomolgus Monkeys of AVI-4658, a Phosphorodiamidate Morpholino Oligomer (PMO) Drug for the Treatment of Duchenne Muscular Dystrophy
- (2011) Peter Sazani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Pip5 Transduction Peptides Direct High Efficiency Oligonucleotide-mediated Dystrophin Exon Skipping in Heart and Phenotypic Correction in mdx Mice
- (2011) HaiFang Yin et al. MOLECULAR THERAPY
- Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
- (2011) Sebahattin Cirak et al. MOLECULAR THERAPY
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Systemic Administration of Unconjugated Morpholino Oligomers for Therapeutic Expression of Dystrophin by Exon Skipping in Skeletal Muscle: Implications for Cardiac Muscle Integrity
- (2011) Alberto Malerba et al. Nucleic Acid Therapeutics
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Diaphragm rescue alone prevents heart dysfunction in dystrophic mice
- (2010) Alastair Crisp et al. HUMAN MOLECULAR GENETICS
- Safety Pharmacology and Genotoxicity Evaluation of AVI-4658
- (2010) Peter Sazani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Optimization of Peptide Nucleic Acid Antisense Oligonucleotides for Local and Systemic Dystrophin Splice Correction in the mdx Mouse
- (2010) HaiFang Yin et al. MOLECULAR THERAPY
- Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
- (2010) Hans Heemskerk et al. MOLECULAR THERAPY
- One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice
- (2010) Bo Wu et al. MOLECULAR THERAPY
- Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials
- (2010) Linda J. Popplewell et al. NEUROMUSCULAR DISORDERS
- Exonic Sequences Provide Better Targets for Antisense Oligonucleotides Than Splice Site Sequences in the Modulation of Duchenne Muscular Dystrophy Splicing
- (2010) Annemieke Aartsma-Rus et al. OLIGONUCLEOTIDES
- Efficacy of systemic morpholino exon-skipping in duchenne dystrophy dogs
- (2009) Toshifumi Yokota et al. ANNALS OF NEUROLOGY
- Cellular Uptake of Neutral Phosphorodiamidate Morpholino Oligomers
- (2009) Patrick Iversen et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
- (2009) Annemieke Aartsma-Rus et al. HUMAN MUTATION
- Cell based therapy for duchenne muscular dystrophy
- (2009) Andrea Farini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- In vivocomparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
- (2009) Hans A. Heemskerk et al. JOURNAL OF GENE MEDICINE
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Update on the management of Duchenne muscular dystrophy
- (2008) A Y Manzur et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function
- (2008) HaiFang Yin et al. HUMAN MOLECULAR GENETICS
- Emergent Dilated Cardiomyopathy Caused by Targeted Repair of Dystrophic Skeletal Muscle
- (2008) DeWayne Townsend et al. MOLECULAR THERAPY
- Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice
- (2008) Natee Jearawiriyapaisarn et al. MOLECULAR THERAPY
- Improved cell-penetrating peptide–PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle
- (2008) Gabriela D. Ivanova et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More